search
Back to results

Physical Training and Cancer-a Multicenter Clinical Trial (Phys-Can)

Primary Purpose

Breast Cancer, Colorectal Cancer, Prostate Cancer

Status
Active
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
high intensity exercise
low/medium intensity exercise
Behavioral medicine strategies
Sponsored by
Uppsala University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Cancer focused on measuring Breast cancer, prostate cancer, colorectal cancer, fatigue, physical exercise, randomised trial, intervention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • understand and talk Swedish.
  • patients with breast cancer who receive neoadjuvant / adjuvant chemotherapy and / or adjuvant radiotherapy and / or adjuvant endocrine treatment.
  • patients with colorectal cancer who receive adjuvant chemotherapy.
  • patients with prostate cancer who receive neoadjuvant / adjuvant endocrine treatment with the addition of curative radiation therapy.

Exclusion Criteria:

  • Patients unable to perform basic activities of daily living.
  • Patients with cognitive disorders such as dementia and severe psychiatric illness.
  • Patients with disabilities that may prevent physical activity: (eg, unstable angina, heart failure, chronic obstructive pulmonary disease, orthopedic and neurological diseases).
  • Breast cancer stage IIIb.
  • Undergoing treatment for other types of malignant disease.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm 4

    Arm Type

    Experimental

    Experimental

    Experimental

    Experimental

    Arm Label

    High intensity

    Low/Medium intensity

    High Intensity with BM

    Low/Medium intensity with BM

    Arm Description

    high intensity exercise 80-90%

    low/medium intensity exercise 40-50%

    high intensity exercise with Behavioral medicine strategies¨ 80-90%

    low/medium intensity exercise with Behavioral medicine strategies 40-50%

    Outcomes

    Primary Outcome Measures

    Change in Fatigue
    Multi Dimensional Fatigue Inventory (MFI),

    Secondary Outcome Measures

    Change in Quality of Life
    The European Organisation for Research and Treatment of Cancer (EORTC)EORTC-QLQ30
    Change in Mood disturbance
    Hospital Anxiety and Depression Scale- (HADs)
    Change in Function in Daily life
    WHO Disability Assessment Schedule
    Change in pain
    Brief Pain Inventory
    Change in Cardio respiratory fitness
    maximal oxygen uptake (VO2 max test)
    Change in Muscle strength
    One Repetition Maximum Lower extremities: One Repetition Maximum (leg press)
    Health Economy
    Euroqol- (EQ5D)
    Cancer recurrence
    number of patients with recurrence
    Sleep
    Insomnia severe index
    Health Economy register
    register data
    Cancer recurrence
    Medical records
    Treatment completion rate
    Medical records

    Full Information

    First Posted
    October 10, 2014
    Last Updated
    November 1, 2022
    Sponsor
    Uppsala University
    Collaborators
    The Swedish Research Council, Swedish Cancer Society, Nordic Cancer Union, Linkoeping University, Lund University, University of Agder, Copenhagen University Hospital, Denmark, Norwegian School of Sport Sciences, Amsterdam UMC, location VUmc, University of Amsterdam, University of Leeds
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02473003
    Brief Title
    Physical Training and Cancer-a Multicenter Clinical Trial
    Acronym
    Phys-Can
    Official Title
    Physical Training and Cancer- Effects and Understanding of Mechanisms for Prevent and Minimizing Cancer Related Fatigue, Improve Quality of Life and Disease Outcome
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2022
    Overall Recruitment Status
    Active, not recruiting
    Study Start Date
    March 2015 (undefined)
    Primary Completion Date
    December 2022 (Anticipated)
    Study Completion Date
    December 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Uppsala University
    Collaborators
    The Swedish Research Council, Swedish Cancer Society, Nordic Cancer Union, Linkoeping University, Lund University, University of Agder, Copenhagen University Hospital, Denmark, Norwegian School of Sport Sciences, Amsterdam UMC, location VUmc, University of Amsterdam, University of Leeds

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Excessive tiredness (fatigue) is a common problem in cancer patients and can affect quality of life negatively. There is limited knowledge about the physical mechanisms that cause fatigue, and there is no medical treatment. Physical activity can reduce the inconvenience, but the investigators need to learn more about the type and intensity of exercise that works the best as well as how to motivate patients to exercise. The overall aim, is to evaluate the efficacy and cost-effectiveness of individually tailored high (H) and low/medium (LM) intensity physical training, with or without behavioural medicine (BM) support strategies, during adjuvant oncological treatment on; Cancer Related Fatigue (CRF),Quality of Life (QoL), mood disturbance, adherence to the cancer treatment, adverse effects, disease outcome, return to a daily life after completed treatment and return to work. The investigators will also describe changes in inflammatory markers and cytokines related to physical training and gene expressions following training to investigate whether these serve as mediators for the effects of physical training on CRF and QoL. This will be evaluated in newly diagnosed breast, colorectal and prostate cancer patients during adjuvant therapy at three different centres in Sweden; Uppsala, Lund/Malmö and Linköping. A 2x2 factorial design will be used, 600 patients will be randomised to H, H+BM, LM or LM+BM. Patients will train two times per week during 6 months. This project will give; new knowledge about aspects for individuals to gain improved well-being and quality of life, facilitated return to work, and possibly reduced risk of cancer recurrence. This in turn would result in lower burden on the health care system, reduced societal costs and have a positive impact on public health. Implementation of the results into clinical practice will be facilitated by the close collaboration between researchers and clinicians, and the fact that the study is performed in clinical settings.
    Detailed Description
    Purpose and Aims The main aim is to determine the effects of high or low intensity physical training with or without integrated behavioral medicine support strategies to prevent and minimize cancer related fatigue (CRF), improve health related quality of life (QoL) and to understand the role of inflammation and cytokines in the development and maintenance of CRF, as well as to increase knowledge with respect to cost-effectiveness of rehabilitation programs. This will be evaluated in newly diagnosed breast, colorectal and prostate cancer patients during adjuvant therapy at three different centers in Sweden; Uppsala, Lund/Malmö and Linköping and one in Norway. More specifically, the investigators' objectives are to: Investigate the effects of high intensity training compared to low intensity training on patient reported outcomes (CRF as primary endpoint), chemotherapy/radiation completion rates, medical (oncology) adverse effects, physical activity and daily function, during adjuvant treatment and at long-term-follow up. In addition, effects on the course of disease (e.g time to relapse). Investigate if supplemental behavioural medicine support strategies increase adherence to exercise during adjuvant therapy and further if they increase the maintenance of physical activity behaviours and decrease sedentary time in the long run. Explore the role of changes in inflammatory markers and cytokines related to physical training and following training to investigate whether these serve as mediators for the effects of physical training on CRF and QoL. Pursue the investigation of a direct role of cytokines secreted from the working muscles, in inhibiting cancer cell growth and inducing apoptosis. Evaluate health economic issues; cost effectiveness of the interventions, health production and individual wellbeing. In Phys-Can, the investigators will implement rigorously designed and adequately powered randomized longitudinal multicenter clinical trials, with physical training and behavioral medicine support interventions. The highly multi- and interdisciplinary and international consortium behind this proposal is in an excellent position to perform international and interdisciplinary competence- and network-building activities to generate valid, high quality data covering all areas included in the project, from basic biomedical data to patient reported outcomes (PROs), i.e. from bench to bedside. This is unique in health care sciences. Study design A 2x2 factorial design will be used. With this design the investigators can study main effects and interactions between factors (groups). Patients will be randomized to one of the following groups; A) individually tailored high intensity training twice a week with (H+BM) or without behavioral medicine support strategies (H) or B) individually tailored low intensity training twice a week with (L+BM) or without behavioral medicine support strategies (L). Study sample/procedure Patients, who are recently diagnosed with breast cancer, colorectal cancer or prostate cancer and scheduled for adjuvant therapy at Uppsala, Lund/Malmö, Linköping and Haukeland University hospitals will be consecutively included in the study. Based on the power calculation, 612 patients will be included. All patients will exercise twice a week during 6 months which is equal to the most extensive adjuvant treatment period. It is also an optimal period to achieve physical training effects and to establish physical activity behavior. Physical training under the guidance of trained coaches will be offered twice a week. Training intensity is 40-50% (low intensity group) or 80-90% (high intensity group) of maximal cardiorespiratory fitness/muscular strength. Physical training sessions consist of both cardiorespiratory and resistance exercise. Every four week, progress from resistance training is evaluated by means of a strength test, and absolute intensity is adjusted accordingly Motivational and self-regulatory behavioral medicine support strategies (motivational and self-regulatory strategies) will be provided for the H+BM and the L+BM groups i.e. strategies to enhance engagement in the high and low intensity exercise programs respectively, and to maintain health enhancing physical activity after the completion of the programs.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Breast Cancer, Colorectal Cancer, Prostate Cancer
    Keywords
    Breast cancer, prostate cancer, colorectal cancer, fatigue, physical exercise, randomised trial, intervention

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    600 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    High intensity
    Arm Type
    Experimental
    Arm Description
    high intensity exercise 80-90%
    Arm Title
    Low/Medium intensity
    Arm Type
    Experimental
    Arm Description
    low/medium intensity exercise 40-50%
    Arm Title
    High Intensity with BM
    Arm Type
    Experimental
    Arm Description
    high intensity exercise with Behavioral medicine strategies¨ 80-90%
    Arm Title
    Low/Medium intensity with BM
    Arm Type
    Experimental
    Arm Description
    low/medium intensity exercise with Behavioral medicine strategies 40-50%
    Intervention Type
    Behavioral
    Intervention Name(s)
    high intensity exercise
    Intervention Description
    high intensity exercise 80-90%
    Intervention Type
    Behavioral
    Intervention Name(s)
    low/medium intensity exercise
    Intervention Description
    low/medium intensity exercise 40-50%
    Intervention Type
    Behavioral
    Intervention Name(s)
    Behavioral medicine strategies
    Intervention Description
    Motivational and self-regulatory behavioral medicine support strategies
    Primary Outcome Measure Information:
    Title
    Change in Fatigue
    Description
    Multi Dimensional Fatigue Inventory (MFI),
    Time Frame
    post oncol treatment (expected time frame 6-8 weeks), 6 month, 1,2,5 years
    Secondary Outcome Measure Information:
    Title
    Change in Quality of Life
    Description
    The European Organisation for Research and Treatment of Cancer (EORTC)EORTC-QLQ30
    Time Frame
    post oncol treatment (expected time frame 6-8 weeks), 6 month, 1,2,5 years
    Title
    Change in Mood disturbance
    Description
    Hospital Anxiety and Depression Scale- (HADs)
    Time Frame
    post oncol treatment (expected time frame 6-8 weeks), 6 month, 1,2,5 years
    Title
    Change in Function in Daily life
    Description
    WHO Disability Assessment Schedule
    Time Frame
    6 months,1, 2, 5 years
    Title
    Change in pain
    Description
    Brief Pain Inventory
    Time Frame
    post oncol treatment (expected time frame 6-8 weeks), 6 month, 1,2,5 years
    Title
    Change in Cardio respiratory fitness
    Description
    maximal oxygen uptake (VO2 max test)
    Time Frame
    6 month
    Title
    Change in Muscle strength
    Description
    One Repetition Maximum Lower extremities: One Repetition Maximum (leg press)
    Time Frame
    6 months
    Title
    Health Economy
    Description
    Euroqol- (EQ5D)
    Time Frame
    12 months
    Title
    Cancer recurrence
    Description
    number of patients with recurrence
    Time Frame
    10 year
    Title
    Sleep
    Description
    Insomnia severe index
    Time Frame
    6 months
    Title
    Health Economy register
    Description
    register data
    Time Frame
    12 months
    Title
    Cancer recurrence
    Description
    Medical records
    Time Frame
    6 months, 1, 2, 5, 10 years
    Title
    Treatment completion rate
    Description
    Medical records
    Time Frame
    1, 2, 5, 10 year

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: understand and talk Swedish. patients with breast cancer who receive neoadjuvant / adjuvant chemotherapy and / or adjuvant radiotherapy and / or adjuvant endocrine treatment. patients with colorectal cancer who receive adjuvant chemotherapy. patients with prostate cancer who receive neoadjuvant / adjuvant endocrine treatment with the addition of curative radiation therapy. Exclusion Criteria: Patients unable to perform basic activities of daily living. Patients with cognitive disorders such as dementia and severe psychiatric illness. Patients with disabilities that may prevent physical activity: (eg, unstable angina, heart failure, chronic obstructive pulmonary disease, orthopedic and neurological diseases). Breast cancer stage IIIb. Undergoing treatment for other types of malignant disease.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Karin Nordin, Professor
    Organizational Affiliation
    Uppsala University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    36269530
    Citation
    Schauer T, Henriksson A, Strandberg E, Lindman H, Berntsen S, Demmelmaier I, Raastad T, Nordin K, Christensen JF. Pre-treatment levels of inflammatory markers and chemotherapy completion rates in patients with early-stage breast cancer. Int J Clin Oncol. 2023 Jan;28(1):89-98. doi: 10.1007/s10147-022-02255-0. Epub 2022 Oct 21.
    Results Reference
    derived
    PubMed Identifier
    35964124
    Citation
    Brooke HL, Mazzoni AS, Buffart LM, Berntsen S, Nordin K, Demmelmaier I. Patterns and determinants of adherence to resistance and endurance training during cancer treatment in the Phys-Can RCT. BMC Sports Sci Med Rehabil. 2022 Aug 13;14(1):155. doi: 10.1186/s13102-022-00548-5.
    Results Reference
    derived
    PubMed Identifier
    34823494
    Citation
    Mazzoni AS, Brooke HL, Berntsen S, Nordin K, Demmelmaier I. Effect of self-regulatory behaviour change techniques and predictors of physical activity maintenance in cancer survivors: a 12-month follow-up of the Phys-Can RCT. BMC Cancer. 2021 Nov 25;21(1):1272. doi: 10.1186/s12885-021-08996-x.
    Results Reference
    derived
    PubMed Identifier
    33608485
    Citation
    Schauer T, Mazzoni AS, Henriksson A, Demmelmaier I, Berntsen S, Raastad T, Nordin K, Pedersen BK, Christensen JF. Exercise intensity and markers of inflammation during and after (neo-) adjuvant cancer treatment. Endocr Relat Cancer. 2021 Mar;28(3):191-201. doi: 10.1530/ERC-20-0507.
    Results Reference
    derived
    PubMed Identifier
    32909467
    Citation
    Mazzoni AS, Brooke HL, Berntsen S, Nordin K, Demmelmaier I. Exercise Adherence and Effect of Self-Regulatory Behavior Change Techniques in Patients Undergoing Curative Cancer Treatment: Secondary Analysis from the Phys-Can Randomized Controlled Trial. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420946834. doi: 10.1177/1534735420946834.
    Results Reference
    derived
    PubMed Identifier
    31703567
    Citation
    Johnsson A, Demmelmaier I, Sjovall K, Wagner P, Olsson H, Tornberg AB. A single exercise session improves side-effects of chemotherapy in women with breast cancer: an observational study. BMC Cancer. 2019 Nov 8;19(1):1073. doi: 10.1186/s12885-019-6310-0.
    Results Reference
    derived
    PubMed Identifier
    28347291
    Citation
    Berntsen S, Aaronson NK, Buffart L, Borjeson S, Demmelmaier I, Hellbom M, Hojman P, Igelstrom H, Johansson B, Pingel R, Raastad T, Velikova G, Asenlof P, Nordin K. Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome. BMC Cancer. 2017 Mar 27;17(1):218. doi: 10.1186/s12885-017-3197-5.
    Results Reference
    derived

    Learn more about this trial

    Physical Training and Cancer-a Multicenter Clinical Trial

    We'll reach out to this number within 24 hrs